CorVel Corp. 10-Q Summary: Quarter Ended June 30, 1997
Business Context and Reporting Period
This Form 10-Q covers the first quarter of CorVel Corp.'s fiscal year ending March 31, 1998, specifically the three months ended June 30, 1997. CorVel provides managed care services, primarily in the workers' compensation sector, including patient management and provider services. As of June 30, 1997, the company had 4,230,000 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Revenues | $34,024,000 | $29,851,000 |
| Gross Profit | $6,467,000 | $5,390,000 |
| Gross Margin | 19.0% | 18.1% |
| Net Income | $2,275,000 | $2,042,000 |
| Diluted EPS | $0.52 | $0.43 |
| Operating Cash Flow | $2,045,000 | $1,248,000 |
| Cash and Equivalents (End of Period) | $12,429,000 | $17,640,000 |
| Total Assets | $57,534,000 | $58,824,000 (Mar 31, 1997) |
| Working Capital | $26,231,000 | $28,596,000 (Mar 31, 1997) |
Note: The filing does not explicitly list long-term debt; total liabilities consist primarily of current liabilities and deferred taxes.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 14% to $34.0 million, driven by a 20% increase in patient management revenue and a 7% increase in provider revenues. Management noted this growth rate was lower than historical trends, partially due to a national reduction in healthcare expenditure growth.
- Profitability: Gross profit margin improved to 19.0% from 18.1% due to operating efficiencies in patient management, despite pricing pressures in the MedCheck business. Net income rose 11% to $2.275 million.
- Expenses: General and administrative (G&A) expenses increased to $2.8 million (8.2% of revenue) from $2.1 million (7.0% of revenue). This increase was attributed to litigation settlements and costs associated with installing a wide area network (WAN).
- Liquidity: Net working capital decreased by $2.4 million, primarily due to the repurchase of $3.3 million of the company's common stock. Cash and cash equivalents declined by $3.2 million during the quarter.
Outlook, Risks, and Management Commentary
Management believes current cash balances and anticipated internally generated funds are sufficient to meet requirements for the next twelve months. The company expects future growth to depend on processing claims data more efficiently and providing meaningful healthcare information.
Key Risks and Contingencies:
- Regulatory Environment: Evolving state and federal regulations regarding medical review services and managed care networks could increase operational costs or limit market access.
- Competition: Intensifying competition from insurers, HMOs, and PPOs, particularly as legislation allows these entities to manage workers' compensation claims.
- Market Dynamics: Declines in workers' compensation claim volumes and costs in various states could adversely affect business volume.
- Litigation: Potential liability regarding medical treatment recommendations, though the company maintains professional liability insurance.
- Stock Volatility: The company warns that stock price may be volatile due to market trends and variations in operating results.
Investor Verification Checklist
- Verify the sustainability of the 14% revenue growth rate given the noted slowdown in national healthcare expenditure growth.
- Confirm the impact of the new WAN installation on future G&A expense levels.
- Assess the adequacy of the $12.4 million cash balance relative to the company's capital expenditure needs and working capital requirements.
- Review the status of ongoing litigation and the sufficiency of professional liability insurance coverage.
- Monitor state-level regulatory changes regarding workers' compensation and managed care licensing.